Search research articles
Contact Us
Filters
Showing results (111-120 of 193) with videos related to
Page
of 20
Sort By:
ERJ Open Research
|
March 18, 2026
Design of a phase II randomised, double-blind, placebo-controlled, dose-finding trial of BI 1819479 in patients with idiopathic pulmonary fibrosis
Wim A Wuyts, Francesco Bonella, Haruyuki Ishii, et al.
Biomarkers in Medicine
|
July 3, 2020
Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease: a comprehensive review
Miriana d'Alessandro, Laura Bergantini, Paolo Cameli, et al.
The European Respiratory Journal
|
November 13, 2025
Sarcoidosis: A State-Of-The-Art Review
Jelle R Miedema, Francesco Bonella, Katharina Buschulte, et al.
Respiratory Medicine
|
February 1, 2017
FAM13A polymorphism as a prognostic factor in patients with idiopathic pulmonary fibrosis
Chihiro Hirano, Shinichiro Ohshimo, Yasushi Horimasu, et al.
Respiration; International Review of Thoracic Diseases
|
April 12, 2017
Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone
Michael Kreuter, Paolo Spagnolo, Wim Wuyts, et al.
Respiration; International Review of Thoracic Diseases
|
July 20, 2018
Metformin Does Not Affect Clinically Relevant Outcomes in Patients with Idiopathic Pulmonary Fibrosis
Paolo Spagnolo, Michael Kreuter, Toby M Maher, et al.
Respiratory Medicine
|
September 22, 2012
Different MUC1 gene polymorphisms in German and Japanese ethnicities affect serum KL-6 levels
Yasushi Horimasu, Noboru Hattori, Nobuhisa Ishikawa, et al.
Annals of the Rheumatic Diseases
|
October 10, 2020
Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)
Paolo Spagnolo, Oliver Distler, Christopher J Ryerson, et al.
Respiratory Research
|
November 11, 2024
Serum soluble isoform of receptor for advanced glycation end product is a predictive biomarker for acute exacerbation of idiopathic pulmonary fibrosis: a German and Japanese cohort study
Erika Kitadai, Kakuhiro Yamaguchi, Shinichiro Ohshimo, et al.
European Radiology Experimental
|
October 14, 2024
CT-based body composition analysis and pulmonary fat attenuation volume as biomarkers to predict overall survival in patients with non-specific interstitial pneumonia
Luca Salhöfer, Francesco Bonella, Mathias Meetschen, et al.
Page
of 20
Search research articles
Search
Showing results (111-120 of 193) with videos related to
Sort By:
Page
of 20
ERJ Open Research
|
March 18, 2026
Design of a phase II randomised, double-blind, placebo-controlled, dose-finding trial of BI 1819479 in patients with idiopathic pulmonary fibrosis
Wim A Wuyts, Francesco Bonella, Haruyuki Ishii, et al.
Biomarkers in Medicine
|
July 3, 2020
Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease: a comprehensive review
Miriana d'Alessandro, Laura Bergantini, Paolo Cameli, et al.
The European Respiratory Journal
|
November 13, 2025
Sarcoidosis: A State-Of-The-Art Review
Jelle R Miedema, Francesco Bonella, Katharina Buschulte, et al.
Respiratory Medicine
|
February 1, 2017
FAM13A polymorphism as a prognostic factor in patients with idiopathic pulmonary fibrosis
Chihiro Hirano, Shinichiro Ohshimo, Yasushi Horimasu, et al.
Respiration; International Review of Thoracic Diseases
|
April 12, 2017
Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone
Michael Kreuter, Paolo Spagnolo, Wim Wuyts, et al.
Respiration; International Review of Thoracic Diseases
|
July 20, 2018
Metformin Does Not Affect Clinically Relevant Outcomes in Patients with Idiopathic Pulmonary Fibrosis
Paolo Spagnolo, Michael Kreuter, Toby M Maher, et al.
Respiratory Medicine
|
September 22, 2012
Different MUC1 gene polymorphisms in German and Japanese ethnicities affect serum KL-6 levels
Yasushi Horimasu, Noboru Hattori, Nobuhisa Ishikawa, et al.
Annals of the Rheumatic Diseases
|
October 10, 2020
Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)
Paolo Spagnolo, Oliver Distler, Christopher J Ryerson, et al.
Respiratory Research
|
November 11, 2024
Serum soluble isoform of receptor for advanced glycation end product is a predictive biomarker for acute exacerbation of idiopathic pulmonary fibrosis: a German and Japanese cohort study
Erika Kitadai, Kakuhiro Yamaguchi, Shinichiro Ohshimo, et al.
European Radiology Experimental
|
October 14, 2024
CT-based body composition analysis and pulmonary fat attenuation volume as biomarkers to predict overall survival in patients with non-specific interstitial pneumonia
Luca Salhöfer, Francesco Bonella, Mathias Meetschen, et al.
Page
of 20